Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents

NCT00044265 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00044265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2002
Completion date
November 30, 2004
Enrollment
310
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension